• No results found

Influensavaksine – til hvem?

N/A
N/A
Protected

Academic year: 2022

Share "Influensavaksine – til hvem?"

Copied!
3
0
0

Laster.... (Se fulltekst nå)

Fulltekst

Referanser

RELATERTE DOKUMENTER

We used the virological data reported weekly by the national reference laboratories for influ- enza and the National Influenza Centres (NICs) to describe the viro- logical, genetic

Since the outbreak of the novel A(H1N1)pdm09, post- pandemic studies have described the clinical aspects of this virus.. and underlying conditions have been associated with

1 Hazard ratios (HRs) of fetal death in the second or third tri- mester, with associated 95% confidence intervals (CIs), between women with and without a diagnosis of

Poor pregnancy outcomes associated with maternal infection with the A(H1N1) 2009 virus during the pandemic – findings from a European cohort study.. Håberg SE, Trogstad L, Gunnes N

The most common cause of viral LRTI is RNA viruses: respiratory syncytial virus (RSV), human parainfluenza virus (PIV), influenza virus, and human metapneumovirus (hMPV).. Adenovirus

Cytotoxic T cells recognize virus infected cells by T cell receptor recognizing and binding to MHC class I protein on the surface of the virus infected cell. Viral peptide

This study aimed to characterize the spatiotemporal distribution of the influenza A pandemic in the Brazilian state of Parana´ from the introduction of the H1N1 virus until the end

Targeting MHCII molecules have been shown to significantly increase antibody responses after vaccination and confers sterilizing immunity against H1 influenza in mice [172],